Latest News

Private equity giant EQT revives plans for $20 billion Galderma IPO- FT


Private equity giant EQT revives plans for $20 billion Galderma IPO- FT By Reuters

Breaking News


Stock Markets

Published Feb 04, 2024 05:48
Updated Feb 04, 2024 08:10

© Reuters.

(Reuters) -Swedish private equity giant EQT is reviving plans for an initial public offering of Swiss skincare group Galderma, the Financial Times reported on Sunday, citing people familiar with the matter.

Galderma is preparing for an IPO in Switzerland as soon as the first half of this year, the report said, adding the unit could be valued at roughly $20 billion.

EQT declined to comment, while Galderma did not respond to a Reuters request for comment.

A source told Reuters last year that owners of Galderma had postponed plans for an IPO due to a crisis of confidence in the banking sector.

Soon after delaying its stock market listing, the company in June raised roughly $1 billion though a private placement of shares.

EQT had acquired Galderma – then Nestle’s Skin Health arm – in 2019 as part of an investor consortium that also included the Abu Dhabi Investment Authority (ADIA) and Canadian pension fund PSP Investments.

Private equity giant EQT revives plans for $20 billion Galderma IPO- FT

Our Apps

Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information

© 2007-2024 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Dividend Royalty: 5 Fabulous Stocks to Buy Now for Decades of Passive Income

Previous article

Northern Ireland appoints Irish nationalist as First Minister in historic shift

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News